Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Oct;38(4):537–543. doi: 10.1038/bjc.1978.241

Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat.

J K Reddy, M S Rao
PMCID: PMC2009753  PMID: 728341

Abstract

Diethylnitrosamine (DEN), at a concentration of 100 parts/10(6) in drinking water for 14 days, caused the development, by 48 weeks, of very few liver tumours in 5 of 18 (27%) male F=344 rats fed control diet. When the DEN treatment was followed one week later by continuous feeding of the hypolipidemic hepatic peroxisome proliferator, Wy-14,643, at 0.1% dietary level, all of 28 rats (100%) developed, between 38 and 48 weeks, a significantly higher number of liver tumours. Furthermore, laparotomy at 22 weeks revealed that several rats fed Wy-14,643 after DEN initiation had developed visible liver nodules, suggesting that Wy-14,643 also accelerates the appearance of these tumours. Administration of another peroxisome proliferator, clofibrate, at 0.5% level in the diet after DEN initiation, also caused a substantial enhancement of liver tumorigenesis. The enhancement of liver-tumour development by clofibrate, however, was less than that by Wy-14,643. The marked enhancing effect of Wy-14,643 may be due to its profound hepatomegalic and peroxisome proliferative properties.

Full text

PDF
537

Images in this article

539Fig. 1
on p.539
540Fig. 2
on p.540
541Fig. 3
on p.541
541Fig. 4
on p.541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barka T., Popper H. Liver enlargement and drug toxicity. Medicine (Baltimore) 1967 Mar;46(2):103–117. doi: 10.1097/00005792-196703000-00005. [DOI] [PubMed] [Google Scholar]
  2. Boutwell R. K. The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol. 1974 Jan;2(4):419–443. doi: 10.3109/10408447309025704. [DOI] [PubMed] [Google Scholar]
  3. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  4. Craddock V. M. Liver carcinomas induced in rats by single administration of dimethylnitrosamine after partial hepatectomy. J Natl Cancer Inst. 1971 Oct;47(4):899–907. [PubMed] [Google Scholar]
  5. Feinstein R. N., Fry R. J., Staffeldt E. F. Carcinogenic and antitumor effects of aminotriazole on acatalasemic and normal catalase mice. J Natl Cancer Inst. 1978 May;60(5):1113–1116. doi: 10.1093/jnci/60.5.1113. [DOI] [PubMed] [Google Scholar]
  6. Frei J. V., Harsono T. Increased susceptibility to low doses of a carcinogen of epidermal cells in stimulated DNA synthesis. Cancer Res. 1967 Aug;27(8):1482–1484. [PubMed] [Google Scholar]
  7. Frei J. V. Some mechanisms operative in carcinogenesis a review. Chem Biol Interact. 1976 Apr;13(1):1–25. doi: 10.1016/0009-2797(76)90010-7. [DOI] [PubMed] [Google Scholar]
  8. GLINOS A. D., BUCHER N. L. R., AUB J. C. The effect of liver regeneration on tumor formation in rats fed 4-dimethylaminoazobenzene. J Exp Med. 1951 Apr 1;93(4):313–325. doi: 10.1084/jem.93.4.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hess R., Stäubli W., Riess W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature. 1965 Nov 27;208(5013):856–858. doi: 10.1038/208856a0. [DOI] [PubMed] [Google Scholar]
  10. Hollander C. F., Bentvelzen P. Enhancement of urethan induction of hepatomas in mice by prior partial hepatectomy. J Natl Cancer Inst. 1968 Dec;41(6):1303–1306. [PubMed] [Google Scholar]
  11. Moody D. E., Rao M. S., Reddy J. K. Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin. Virchows Arch B Cell Pathol. 1977 Apr 15;23(4):291–296. doi: 10.1007/BF02889139. [DOI] [PubMed] [Google Scholar]
  12. Moody D. E., Reddy J. K. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes. Am J Pathol. 1978 Feb;90(2):435–446. [PMC free article] [PubMed] [Google Scholar]
  13. POUND A. W., WITHERS H. R. THE INFLUENCE OF SOME IRRITANT CHEMICALS AND SCARIFICATION ON TUMOUR INITIATION BY URETHANE IN MICE. Br J Cancer. 1963 Sep;17:460–470. doi: 10.1038/bjc.1963.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Peraino C., Fry R. J., Staffeldt E., Christopher J. P. Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res. 1975 Oct;35(10):2884–2890. [PubMed] [Google Scholar]
  15. Peraino C., Fry R. J., Staffeldt E. Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res. 1977 Oct;37(10):3623–3627. [PubMed] [Google Scholar]
  16. Peraino C., Fry R. J., Staffeldt E. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 1971 Oct;31(10):1506–1512. [PubMed] [Google Scholar]
  17. Poound A. W., McGuire L. J. Influence of repeated liver regeneration on hepatic carcinogenesis by diethylnitrosamine in mice. Br J Cancer. 1978 Apr;37(4):595–602. doi: 10.1038/bjc.1978.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pound A. W., McGuire L. J. Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rats. Br J Cancer. 1978 Apr;37(4):585–594. doi: 10.1038/bjc.1978.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Reddy J. K., Azarnoff D. L., Svoboda D. J., Prasad J. D. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response. J Cell Biol. 1974 May;61(2):344–358. doi: 10.1083/jcb.61.2.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Reddy J. K., Krishnakantha T. P. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science. 1975 Nov 21;190(4216):787–789. doi: 10.1126/science.1198095. [DOI] [PubMed] [Google Scholar]
  21. Reddy J. K., Rao M. S., Jago M. V. Rapid development of hyperplastic nodules and cirrhosis in the liver of rats treated concurrently with thioacetamide and the pyrrolizidine alkaloid lasiocarpine. Int J Cancer. 1976 May 15;17(5):621–625. doi: 10.1002/ijc.2910170510. [DOI] [PubMed] [Google Scholar]
  22. Reddy J. K., Rao M. S. Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator. J Natl Cancer Inst. 1977 Dec;59(6):1645–1650. doi: 10.1093/jnci/59.6.1645. [DOI] [PubMed] [Google Scholar]
  23. Reddy J. K., Rao S., Moody D. E. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res. 1976 Apr;36(4):1211–1217. [PubMed] [Google Scholar]
  24. SALAMAN M. H., ROE F. J. COCARCINOGENESIS. Br Med Bull. 1964 May;20:139–144. doi: 10.1093/oxfordjournals.bmb.a070307. [DOI] [PubMed] [Google Scholar]
  25. Schulte-Hermann R. Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit Rev Toxicol. 1974 Sep;3(1):97–158. doi: 10.3109/10408447409079856. [DOI] [PubMed] [Google Scholar]
  26. Slaga T. J., Scribner J. D., Viaje A. Epidermal cell proliferation and promoting ability of phorbol esters. J Natl Cancer Inst. 1976 Nov;57(5):1145–1149. doi: 10.1093/jnci/57.5.1145. [DOI] [PubMed] [Google Scholar]
  27. Svoboda D., Grady H., Azarnoff D. Microbodies in experimentally altered cells. J Cell Biol. 1967 Oct;35(1):127–152. doi: 10.1083/jcb.35.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Weisburger J. H., Madison R. M., Ward J. M., Viguera C., Weisburger E. K. Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppression. J Natl Cancer Inst. 1975 May;54(5):1185–1188. doi: 10.1093/jnci/54.5.1185. [DOI] [PubMed] [Google Scholar]
  29. Yuspa S. H., Hennings H., Saffiotti U. Cutaneous chemical carcinogenesis: past, present, and future. J Invest Dermatol. 1976 Jul;67(1):199–208. doi: 10.1111/1523-1747.ep12513040. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES